![Alexander M. Gold](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alexander M. Gold
Directeur/Bestuurslid bij MINERALYS THERAPEUTICS, INC.
Vermogen: - $ op 31-05-2024
Actieve functies van Alexander M. Gold
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
MINERALYS THERAPEUTICS, INC. | Directeur/Bestuurslid | 13-06-2024 | - |
Independent Dir/Board Member | 13-06-2024 | - |
Loopbaan van Alexander M. Gold
Eerdere bekende functies van Alexander M. Gold
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2013 | 01-10-2017 |
REATA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2012 | - |
AstraZeneca LP
![]() AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Directeur/Bestuurslid | 01-01-2001 | - |
Sanifit Therapeutics SA
![]() Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Hoofd Techniek/Wetenschap/O&O | - | - |
President | - | - |
Opleiding van Alexander M. Gold
Brandeis University | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Spanje | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MINERALYS THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Portola Pharmaceuticals LLC
![]() Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Reata Pharmaceuticals, Inc.
![]() Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
AstraZeneca LP
![]() AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Sanifit Therapeutics SA
![]() Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Health Technology |
- Beurs
- Insiders
- Alexander M. Gold
- Ervaring